Synthetic Low-Molecular Weight Thrombin Inhibitors: The Ideal Antithrombotic Drug? an Introduction
- 1 January 1995
- journal article
- research article
- Published by Taylor & Francis in Journal of Enzyme Inhibition
- Vol. 9 (1), 1-2
- https://doi.org/10.3109/14756369509040676
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profileTrends in Pharmacological Sciences, 1993
- Complexation of benzamidinium by a new family of artificial receptorsJournal of the American Chemical Society, 1992
- Kinetic Considerations on the Physiologic Control of Thrombin and Factor XaSeminars in Thrombosis and Hemostasis, 1992
- Anticoagulant activity of a peptide boronic acid thrombin inhibitor by various routes of administration in ratsPeptides, 1991
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.JCI Insight, 1990
- Highly active and selective anticoagulants: D-Phe-Pro-Arg-H, a free tripeptide aldehyde prone to spontaneous inactivation, and its stable N-methyl derivative, D-MePhe-Pro-Arg-HJournal of Medicinal Chemistry, 1990
- Thrombin-Elicited Contractile Responses of Aortic Smooth MuscleExperimental Biology and Medicine, 1985